Cytokinetics CYTK Q1 2025 earnings
Reported May 6, 2025 · After market close
Revenue estimate$2.8M
EPS estimate-$1.41
Next report
Aug 6, 2026 (In 3 weeks)Revenue estimate$17.1M
EPS estimate-$1.64
Financials
Q1 2025Valuation & ratios
Segments
By product
Versus estimates
Revenue
Diluted EPS
Ask the moment Cytokinetics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Cytokinetics report Q1 2025 earnings?
- Cytokinetics (CYTK) reported Q1 2025 earnings on May 6, 2025 after market close.
- What were Cytokinetics's Q1 2025 revenue and EPS?
- Cytokinetics reported revenue of $1.6M and diluted EPS of $-1.36 for Q1 2025.
- Did Cytokinetics beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $2.8M by $1.2M. EPS beat the consensus estimate of $-1.41 by $0.05.
- How did Cytokinetics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 89.1% from $835.0K a year earlier and diluted EPS declined 2.3% from $-1.33.
- Where can I find Cytokinetics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-064529) directly on SEC EDGAR. The filing index links above go to sec.gov.